PlatPhorm Podcasts

The Daily

This is what the news should sound like. The biggest stories of our time, told by the best journalists in the world. Hosted by Michael Barbaro, Rachel Abrams and Natalie Kitroeff. Twenty minutes a day, six days a week, ready by 6 a.m. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher.

Open publisher feed

25 indexed items · language not specified · active

Open feed

Community rank is loading…

Episodes

4/26/2026

Daniel Radcliffe, Mariska Hargitay and the Happiest List on Earth artwork

episode · Checking source

Daniel Radcliffe, Mariska Hargitay and the Happiest List on Earth

The Daily

With war, political wrangling and price hikes jockeying for headlines, it’s a rare thing to sit for an hour with a large group of strangers and focus on the small pleasures in life. But that’s what the show “Every Brilliant Thing” is all about. Since 2013, Duncan Macmillan’s audience-participation-heavy play has been performed in dozens of languages in hundreds of locations across the globe. It revolves around a central character who writes a list of all the good things in life for a depressed parent. And while it tackles dark subject matter — including frequent mentions of a loved one’s suicide — it may be one of the funniest shows about depression, ever. In this episode of “The Sunday Daily,” Michael Barbaro talks with Daniel Radcliffe, who currently stars in a Broadway production of the show, and Mariska Hargitay, who will step into the role in a few weeks. We’ll also hear from the playwright and several other actors who have performed the play on stages, in living rooms, on basketball courts and aircraft carriers all over the world. On today's episode: Daniel Radcliffe Mariska Hargitay Duncan Macmillan Candunn Jennette Greg Dragas Mugambi Nthiga Erika de la Vega Jung Sae-Byul Mohsina Akhter Tommy Schoffler Nanda Mohammad Background reading: ‘Every Brilliant Thing,’ Now Starring Daniel Radcliffe and You Daniel Radcliffe Makes ‘Every Brilliant Thing’ Shine Daniel Radcliffe Wanted a Break From Broadway. Then He Read This Play. Photo credit: Sara Krulwich/The New York Times For more information on today’s episode, visit nytimes.com/thedaily . Transcripts of each episode will be made available by the next workday. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher . For more podcasts and narrated articles, download The New York Times app at nytimes.com/app. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

View original

4/19/2026

Dating on the Spectrum artwork

episode · Checking source

Dating on the Spectrum

The Daily

The reality show “Love on the Spectrum” — which just released its fourth season — has become a big hit; it’s currently one of the most watched shows on Netflix in the United States. The show follows autistic adults as they search for love. “Love on the Spectrum” is unlike much of reality television — a genre known to subject its cast members to drama and humiliation for entertainment’s sake. Instead, the show captures a dating world that has more heartwarming moments than histrionics, and is sensitive and nuanced in its portrayal of neurodivergent people. On today’s episode of “The Sunday Daily,” Rachel Abrams talks with Anna Peele, a contributing writer for The New York Times, about the show’s origin story and why it has resonated with so many people. On Today’s Episode: Anna Peele is a contributing writer to The New York Times Magazine and the author of the forthcoming book “Enter the Villa,” about the reality show “Love Island.” Photo credit: Ryan Pfluger for The New York Times. For more information on today’s episode, visit nytimes.com/thedaily . Transcripts of each episode will be made available by the next workday. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher . For more podcasts and narrated articles, download The New York Times app at nytimes.com/app. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

View original

4/12/2026

One Reporter’s Life-Altering Psychedelic Trip artwork

episode · Checking source

One Reporter’s Life-Altering Psychedelic Trip

The Daily

The first time Robert Draper heard about the psychedelic drug ibogaine, it was from an unlikely source: the retired U.S. senator Kyrsten Sinema. As a political reporter for The New York Times, Draper often talks to figures like Ms. Sinema. But on this occasion, he said, she wanted to tell him about how she had tried ibogaine, which is illegal in the United States. She’d become such a believer in the drug that she was pushing her home state of Arizona to fund clinical trials for veterans with combat-related trauma. Draper found that Ms. Sinema wasn’t the only politician to take up the cause. Rick Perry, the former Texas governor, Republican presidential candidate and Trump energy secretary, has also advocated for research into ibogaine in recent years and taken the drug himself. In 2025, because of Mr. Perry’s efforts, Texas became the first state to dedicate public funds to ibogaine research with veterans. Recent studies of ibogaine at Stanford University and elsewhere suggest that it might prove effective in treating post-traumatic stress disorder, traumatic brain injuries, addiction and a range of other conditions. As Draper reported on ibogaine’s transformative effects on others, he wondered: Could it help him , too? Today, on “The Sunday Daily,” Natalie Kitroeff talks to Robert Draper about what drew him to travel to Mexico to try ibogaine, and how his trip changed his life. On Today’s Episode: Robert Draper (usually) writes about domestic politics for The New York Times. Background Reading: It’s an Obscure Psychedelic Used to Treat Trauma. Could It Help Me? The Long, Strange Trip of Rick Perry Art Credit: Illustration By Melissa Santamaría For more information on today’s episode, visit nytimes.com/thedaily . Transcripts of each episode will be made available by the next workday. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher . For more podcasts and narrated articles, download The New York Times app at nytimes.com/app. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

View original

4/5/2026

She Risked Her Voice to Become a Mother artwork

episode · Checking source

She Risked Her Voice to Become a Mother

The Daily

Lise Davidsen is one of the greatest opera singers of our time — a soprano with a voice so rare, critics reach back a century for comparison. This spring, she has been starring in a sold-out new production of Wagner’s “Tristan und Isolde” at the Metropolitan Opera. But she’s also at a crossroads: Her first performance as “Isolde” on the Met stage came just nine months after giving birth to twins. Today on The Sunday Daily, Natalie Kitroeff talks with the Times writer Zachary Woolfe about his recent conversation with Davidsen, and the unexpected emotional weight she felt while returning to the stage as a new mother. They discuss how a production centered on birth, death and renewal gave Davidsen a way to work through this seismic shift in her life, all while tackling the role of a lifetime. On Today’s Episode: Zachary Woolfe is a writer and editor for The New York Times. Background Reading: With Twin Babies, the Opera Star Lise Davidsen Wonders What Comes Next The Met Opera’s Desperate Hunt for Money Photo credit: Amir Hamja for The New York Times For more information on today’s episode, visit nytimes.com/thedaily . Transcripts of each episode will be made available by the next workday. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher . For more podcasts and narrated articles, download The New York Times app at nytimes.com/app. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

View original

3/29/2026

Our Enduring Fascination With the Kennedys artwork

episode · Checking source

Our Enduring Fascination With the Kennedys

The Daily

“Love Story,” the FX limited series about John F. Kennedy Jr. and Carolyn Bessette’s relationship, has taken audiences by storm. Its unstoppable wave of ’90s nostalgia has swept through the world of fashion, revitalized iconic New York landmarks and set off a yearning for simpler days before smartphones and dating apps. The series has also drawn significant backlash, with criticism ranging from bad reviews to accusations of inaccuracy and even harm. Today, Rachel Abrams talks to Alexandra Jacobs, a critic for The New York Times Book Review, about why America can’t seem to look away from “Love Story.” On Today’s Episode: Alexandra Jacobs , a critic for The New York Times Book Review and occasional features writer. Background Reading: The Lasting Appeal of John F. Kennedy Jr. Daryl Hannah: How Can ‘Love Story’ Get Away With This? For more information on today’s episode, visit nytimes.com/thedaily . Transcripts of each episode will be made available by the next workday. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher . For more podcasts and narrated articles, download The New York Times app at nytimes.com/app. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

View original